In another study, NLRP3 inflammasome-associated genes (ASC, caspase-1, and NLRP3) were significantly upregulated in patients with NASH (Csak et al., 2011). This evidence concerns the gene CASP1 and metabolic dysfunction-associated steatohepatitis.